CHARLES M BALCH to Clinical Trials as Topic
This is a "connection" page, showing publications CHARLES M BALCH has written about Clinical Trials as Topic.
Connection Strength
0.518
-
Surgery: Limitations of prospective surgical oncology trials - a US view. Nat Rev Clin Oncol. 2016 Jan; 13(1):6-8.
Score: 0.261
-
How patient referral bias can confuse interpretation of clinical results: elective lymph node dissections at the Sydney Melanoma Unit. J Am Coll Surg. 1995 Apr; 180(4):490-2.
Score: 0.062
-
New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003; 21(1):43-52.
Score: 0.027
-
Scientific data from clinical trials: investigators' responsibilities and rights. J Am Coll Surg. 2002 Jun; 194(6):851-2.
Score: 0.026
-
Consensus statement on scientific data from clinical trials and investigators' responsibilities and rights. Am J Surg. 2002 Jun; 183(6):605-6.
Score: 0.026
-
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000 Mar 15; 88(6):1484-91.
Score: 0.022
-
Finally, a successful adjuvant therapy for high-risk melanoma. J Clin Oncol. 1996 Jan; 14(1):1-3.
Score: 0.016
-
Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. Cancer Treat Rev. 2014 Oct; 40(9):1056-64.
Score: 0.015
-
Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma. Mayo Clin Proc. 2011 Jun; 86(6):522-8.
Score: 0.012
-
The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol. 1988 Jan; 6(1):163-72.
Score: 0.009
-
The academic surgeon as a clinical investigator. J Surg Res. 1986 May; 40(5):413-20.
Score: 0.008
-
Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma. Surgery. 1984 Apr; 95(4):454-9.
Score: 0.007
-
A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg. 1983 Nov; 198(5):567-73.
Score: 0.007
-
The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg. 1983 Aug; 198(2):164-7.
Score: 0.007
-
A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapy. Cancer. 1982 Mar 15; 49(6):1079-84.
Score: 0.006
-
Recent advances in the care of the patient with malignant melanoma. Ann Surg. 1997 Jan; 225(1):1-14.
Score: 0.004
-
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg. 1986 Mar; 52(3):148-51.
Score: 0.002